Skip to content
lifestyle.streetregister.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Aro Biotherapeutics
Aro Biotherapeutics Reports Therapeutic Potential of Centyrin – IFIH1 siRNA Conjugate for the Treatment of Type 1 Diabetes
October 12, 2026
Aro Biotherapeutics Appoints Biotechnology Executive Brett Blackman, Ph.D., to its Board of Directors
September 29, 2026